Diametric Capital, LP Harrow Health, Inc. Transaction History

Diametric Capital, LP

$118 Million
Q4 2024

A detailed history of Diametric Capital, LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Diametric Capital, LP holds 110,295 shares of HROW stock, worth $3.36 Million. This represents 3.13% of its overall portfolio holdings.

Number of Shares

110,295

Previous 74,026 48.99%

Holding current value

$3.36 Million

Previous $3.33 Million 11.18%

% of portfolio

3.13%

Previous 1.92%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$33.39 - $57.5 $1.21 Million - $2.09 Million	36,269 Added 48.99%	110,295 $3.7 Million
Q3 2024 Nov 13, 2024	SELL	$20.85 - $46.47 $4.48 Million - $9.99 Million	-214,870 Reduced 74.38%	74,026 $3.33 Million
Q2 2024 Aug 13, 2024	SELL	$10.0 - $21.64 $135,930 - $294,152	-13,593 Reduced 4.49%	288,896 $6.04 Million
Q1 2024 May 15, 2024	BUY	$9.3 - $13.23 $1.45 Million - $2.06 Million	155,441 Added 105.71%	302,489 $4 Million
Q4 2023 Feb 13, 2024	SELL	$8.1 - $16.36 $1.13 Million - $2.28 Million	-139,079 Reduced 48.61%	147,048 $1.65 Million
Q3 2023 Nov 14, 2023	BUY	$14.03 - $22.08 $1.92 Million - $3.02 Million	136,556 Added 91.3%	286,127 $4.11 Million
Q2 2023 Aug 11, 2023	BUY	$17.37 - $28.08 $262,564 - $424,457	15,116 Added 11.24%	149,571 $2.85 Million
Q1 2023 May 11, 2023	SELL	$13.84 - $21.46 $2.19 Million - $3.4 Million	-158,347 Reduced 54.08%	134,455 $2.85 Million
Q4 2022 Mar 29, 2023	BUY	$10.28 - $14.78 $706,359 - $1.02 Million	68,712 Added 30.66%	292,802 $4.32 Million
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $231,980 - $878,487	35,309 Added 18.7%	224,090 $2.71 Million
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.74 $89,717 - $120,767	15,603 Added 9.01%	188,781 $1.37 Million
Q1 2022 May 16, 2022	BUY	$6.77 - $8.66 $366,581 - $468,921	54,148 Added 45.49%	173,178 $1.18 Million
Q4 2021 Feb 14, 2022	BUY	$8.5 - $12.0 $155,269 - $219,204	18,267 Added 18.13%	119,030 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $128,056 - $194,192	18,320 Added 22.22%	100,763 $916,000
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $241,769 - $400,656	36,193 Added 78.26%	82,443 $766,000
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $1.29 Million - $2.28 Million	-206,524 Reduced 81.7%	46,250 $312,000
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $117,043 - $170,401	24,589 Added 10.78%	252,774 $1.73 Million
Q3 2020 Nov 13, 2020	SELL	$4.71 - $7.36 $282,849 - $441,990	-60,053 Reduced 20.83%	228,185 $1.28 Million
Q2 2020 Aug 14, 2020	SELL	$3.61 - $6.47 $833,581 - $1.49 Million	-230,909 Reduced 44.48%	288,238 $1.5 Million
Q1 2020 May 15, 2020	BUY	$3.5 - $7.31 $542,619 - $1.13 Million	155,034 Added 42.58%	519,147 $1.98 Million
Q4 2019 Feb 14, 2020	SELL	$4.6 - $7.88 $148,460 - $254,319	-32,274 Reduced 8.14%	364,113 $2.83 Million
Q3 2019 Nov 13, 2019	BUY	$4.89 - $8.0 $658,800 - $1.08 Million	134,724 Added 51.49%	396,387 $2.23 Million
Q2 2019 Aug 14, 2019	SELL	$4.2 - $8.7 $573,594 - $1.19 Million	-136,570 Reduced 34.29%	261,663 $2.07 Million
Q1 2019 May 15, 2019	BUY	$4.75 - $7.1 $1.89 Million - $2.83 Million	398,233 New	398,233 $1.98 Million

Others Institutions Holding HROW

# of Institutions

187

Shares Held

21.5M

Call Options Held

650K

Put Options Held

1.19M

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $823M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.

Account

Diametric Capital, LP Harrow Health, Inc. Transaction History